Gene-Based Vaccines Could Be Banned in Iowa Under New Bill
If passed, anyone who provides or administers a gene-based vaccine to another person would face a penalty of $500 per ...
Moderna, Inc. (MRNA) TD Cowen 45th Annual Health Care Conference
Moderna, Inc. ( NASDAQ: MRNA) TD Cowen 45th Annual Health Care Conference March 5, 2025 9:10 AM ET All right, well, good morning, everyone. Tyler Van Buren here, Senior Biotech Analyst at TD Cowen.
BioSpace4h
FDA Pauses Study of BioNTech’s Malaria Shot as Problems for Vaccine Space Mount
The vaccine space has been battered by strong headwinds in recent weeks, including high-level disruptions to FDA and CDC ...
agdaily5h
Ag Secretary Rollins lays out strategies for avian flu, egg prices
Just weeks after being sworn into her role as U.S. Agriculture Secretary, Brooke Rollins is focusing on battling the spread ...
Federal health officials want to hear from you about vaccines. Give them an earful.
If the FDA and CDC sit on their hands, next season the flu shot will be a lot more expensive, if you can find it at all. That ...
Channel 300019h
‘Feels like things are getting derailed unnecessarily’: FDA cancels routine advisory meeting for flu vaccine
Public health experts say they are on edge about the upcoming influenza vaccine after the Food and Drug Administration canceled a routine advisory meeting last week.
MedPage Today19h
Marty Makary, Who Made His Name Bashing the Medical Establishment, May Soon Lead FDA
Now the Johns Hopkins University surgeon and researcher has been nominated to lead the FDA. The agency -- responsible for ...
BioNTech SE's RNA-based vaccine for malaria placed on clinical hold by FDA
BioNTech SE (NASDAQ:BNTX) said on Tuesday, that the U.S. Food and Drug Administration informed of a clinical hold on the ...
ABC Kcrg 920h
Bill banning mRNA vaccines in Iowa passes subcommittee
A bill banning gene-based vaccines, like some forms of the COVID-19 vaccine, received approval from a Senate subcommittee ...
FierceBiotech20h
BioNTech's RNA malaria vaccine trial hit by FDA hold
The FDA has placed a hold on BioNTech’s phase 1/2a trial, pausing the company’s efforts to develop a RNA-based vaccine for ...
BioNTech reports FDA clinical hold on Phase I/IIa trial of BNT165e
In a regulatory filing, BioNTech (BNTX) disclosed that the U.S. Food and Drug Administration has informed BioNTech SE that it has placed a ...
U.S. FDA places clinical hold on BioNTech's malaria vaccine study
BioNTech said in a regulatory filing on Tuesday the U.S. Food and Drug Administration has placed a clinical hold on an ...